|
Market Closed -
NYSE
00:00:03 16/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 121.29 USD | +0.15% |
|
+1.52% | +51.33% |
| 10-09 | Barrington Adjusts Price Target on Haemonetics to $140 From $118, Keeps Outperform Rating | MT |
| 10-09 | CSL to Transition US Plasma Centers to Haemonetics' Latest Plasmapheresis Platform | MT |
| Market Cap | 5.52B 4.93B 4.58B 4.16B 7.83B 523B 7.98B 54.99B 21.52B 273B 20.71B 20.27B 873B | P/E 2027 * |
30.6x | P/E 2028 * | 26.9x |
|---|---|---|---|---|---|
| Enterprise Value | 6.18B 5.52B 5.13B 4.66B 8.77B 585B 8.93B 61.59B 24.1B 305B 23.19B 22.7B 977B | EV / Sales 2027 * |
4.36x | EV / Sales 2028 * | 3.91x |
| Free-Float |
98.74% | Yield 2027 * |
0.82% | Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| HAE | Delayed | |
CBOE
| HAE | Real-time | |
|
Boerse Muenchen
| HAZ | Real-time | |
|
Deutsche Boerse AG
| HAZ | Delayed | |
|
Börse Stuttgart
| HAZ | Delayed | |
|
Tradegate
| HAZ | Real-time |
Last Transcript: Haemonetics Corporation
| 1 day | +0.15% | ||
| 1 week | +1.52% | ||
| Current month | +15.19% | ||
| 1 month | +14.21% | ||
| 3 months | +58.18% | ||
| 6 months | +95.79% | ||
| Current year | +51.33% |
| 1 week | 118.36 |  | 123.77 |
| 1 month | 101.32 | | 123.77 |
| Current year | 51 | | 123.77 |
| 1 year | 48.98 | | 123.77 |
| 3 years | 47.32 | | 123.77 |
| 5 years | 43.5 | | 123.77 |
| 10 years | 32.76 | | 142.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 16/05/2016 | |
James D'Arecca
DFI | Director of Finance/CFO | 55 | 11/04/2022 |
Frank Chan
COO | Chief Operating Officer | 56 | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Kroll
BRD | Director/Board Member | 73 | 01/01/2006 |
| Director/Board Member | 62 | 16/05/2016 | |
Robert Abernathy
BRD | Director/Board Member | 71 | 18/10/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 24/07/26 | Free | Director | 2,538 | 0.0056% | ||
| 24/07/26 | Free | Director | 2,538 | 0.0056% | ||
| 24/07/26 | Free | Director | 2,538 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.15% | +1.52% | +149.67% | +35.73% | 5.51B | |
| +2.29% | +6.28% | -19.13% | +15.20% | 178B | |
| +1.29% | +8.77% | +0.12% | +32.64% | 121B | |
| +4.12% | +5.87% | -20.70% | +13.71% | 108B | |
| +0.41% | +3.99% | -44.97% | -9.38% | 75.7B | |
| +1.56% | +6.24% | +6.82% | +80.66% | 64.15B | |
| +2.30% | +2.00% | +15.50% | +68.01% | 53.49B | |
| +2.58% | +6.02% | +3.74% | -25.10% | 51.45B | |
| +3.43% | +6.63% | -14.39% | +28.39% | 41.68B | |
| +1.78% | +2.32% | - | - | 31.52B | |
| Average | +2.00% | +6.60% | +8.52% | +26.65% | 73.02B | |
| Weighted average by Cap. | +2.19% | +5.91% | -10.52% | +23.35% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 1.42B 1.26B 1.18B 1.07B 2.01B 134B 2.05B 14.12B 5.52B 70.02B 5.32B 5.2B 224B | 1.5B 1.33B 1.24B 1.13B 2.12B 142B 2.16B 14.9B 5.83B 73.9B 5.61B 5.49B 236B |
| Net income | 177M 158M 147M 134M 252M 16.8B 256M 1.77B 692M 8.77B 666M 652M 28.06B | 207M 185M 172M 156M 294M 19.63B 300M 2.07B 808M 10.24B 778M 761M 32.77B |
| Net Debt | 662M 591M 549M 500M 940M 62.7B 957M 6.6B 2.58B 32.72B 2.48B 2.43B 105B | 327M 292M 271M 247M 464M 30.98B 473M 3.26B 1.28B 16.17B 1.23B 1.2B 51.73B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | $121.29 | +0.15% | 747,647 |
| 14/10/26 | $121.11 | -0.50% | 592,144 |
| 13/10/26 | $121.72 | -0.28% | 829,194 |
| 12/10/26 | $122.06 | +2.84% | 895,092 |
| 09/10/26 | $118.69 | -0.65% | 1,251,114 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HAE Stock
Select your edition
All financial news and data tailored to specific country editions
